##gff-version 3 Q9H334 UniProtKB Chain 1 677 . . . ID=PRO_0000091877;Note=Forkhead box protein P1 Q9H334 UniProtKB Zinc finger 306 331 . . . Note=C2H2-type Q9H334 UniProtKB DNA binding 465 555 . . . Note=Fork-head;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00089 Q9H334 UniProtKB Region 1 43 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Region 270 298 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Region 348 369 . . . Note=Leucine-zipper Q9H334 UniProtKB Region 382 386 . . . Note=CTBP1-binding;Ontology_term=ECO:0000250;evidence=ECO:0000250 Q9H334 UniProtKB Region 390 422 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Region 611 677 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Compositional bias 1 24 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Compositional bias 270 286 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Compositional bias 390 405 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Compositional bias 611 625 . . . Note=Polar residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q9H334 UniProtKB Site 59 60 . . . Note=Breakpoint for translocation to form PAX5-FOXP1 Q9H334 UniProtKB Modified residue 83 83 . . . Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:23186163;Dbxref=PMID:23186163 Q9H334 UniProtKB Modified residue 653 653 . . . Note=Phosphothreonine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569 Q9H334 UniProtKB Modified residue 658 658 . . . Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569 Q9H334 UniProtKB Cross-link 287 287 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:28112733;Dbxref=PMID:28112733 Q9H334 UniProtKB Cross-link 372 372 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:28112733;Dbxref=PMID:28112733 Q9H334 UniProtKB Cross-link 377 377 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:28112733;Dbxref=PMID:28112733 Q9H334 UniProtKB Cross-link 442 442 . . . Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:28112733;Dbxref=PMID:28112733 Q9H334 UniProtKB Alternative sequence 1 60 . . . ID=VSP_001555;Note=In isoform 3 and isoform 4. MMQESGTETKSNGSAIQNGSGGSNHLLECGGLREGRSNGETPAVDIGAADLAHAQQQQQQ->MFQCVFSSSVLQPHSTSCLFKHLFYHSATPASQKQPEPIYSKKTEIQRQTVRAPFAKLFIFS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 Q9H334 UniProtKB Alternative sequence 61 114 . . . ID=VSP_043462;Note=In isoform 5. ALQVARQLLLQQQQQQQVSGLKSPKRNDKQPALQVPVSVAMMTPQVITPQQMQQ->WHLINHQPSRSPSSWLKRLISSPWELEVLQVPLWGAVAETKMSGPVCQPNPSPF;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.2;Dbxref=PMID:15489334 Q9H334 UniProtKB Alternative sequence 95 170 . . . ID=VSP_001556;Note=In isoform 3 and isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 Q9H334 UniProtKB Alternative sequence 115 677 . . . ID=VSP_043463;Note=In isoform 5. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.2;Dbxref=PMID:15489334 Q9H334 UniProtKB Alternative sequence 450 450 . . . ID=VSP_046930;Note=In isoform 7. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11751404,ECO:0000303|PubMed:14702039;Dbxref=PMID:11751404,PMID:14702039 Q9H334 UniProtKB Alternative sequence 511 551 . . . ID=VSP_057341;Note=In isoform 8. NAVRHNLSLHKCFVRVENVKGAVWTVDEVEFQKRRPQKISG->GAIRTNLSLHKCFIRVEDEFGSFWTVDDEEFKRGRHIQRGRPRKYCPDENFDELVAH;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21924763;Dbxref=PMID:21924763 Q9H334 UniProtKB Natural variant 5 5 . . . ID=VAR_065067;Note=S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848658;Dbxref=dbSNP:rs762898505,PMID:20848658 Q9H334 UniProtKB Natural variant 101 101 . . . ID=VAR_065068;Note=M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848658;Dbxref=dbSNP:rs564508875,PMID:20848658 Q9H334 UniProtKB Natural variant 107 107 . . . ID=VAR_075246;Note=In MRLIAF%3B uncertain significance%3B does not affect nuclear localization%3B no loss of transcriptional repression activity%3B no loss of ability to self-associate%3B no loss of interaction with FOXP2. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26647308,ECO:0000269|PubMed:29463886;Dbxref=PMID:26647308,PMID:29463886 Q9H334 UniProtKB Natural variant 215 215 . . . ID=VAR_065069;Note=Does not affect nuclear localization%3B no loss of transcriptional repression activity%3B no loss of ability to self-associate%3B no loss of interaction with FOXP2. P->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19352412,ECO:0000269|PubMed:20848658,ECO:0000269|PubMed:20950788,ECO:0000269|PubMed:26647308;Dbxref=dbSNP:rs146606219,PMID:19352412,PMID:20848658,PMID:20950788,PMID:26647308 Q9H334 UniProtKB Natural variant 261 261 . . . ID=VAR_065070;Note=S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848658;Dbxref=PMID:20848658 Q9H334 UniProtKB Natural variant 390 390 . . . ID=VAR_065071;Note=T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20848658;Dbxref=dbSNP:rs761840006,PMID:20848658 Q9H334 UniProtKB Natural variant 445 445 . . . ID=VAR_065072;Note=V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20950788;Dbxref=dbSNP:rs147756430,PMID:20950788 Q9H334 UniProtKB Natural variant 465 465 . . . ID=VAR_075247;Note=In MRLIAF%3B nuclear and cytoplasmic aggregation%3B loss of transcriptional repression activity%3B loss of ability to self-associate%3B loss of interaction with FOXP2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26647308;Dbxref=dbSNP:rs869025202,PMID:26647308 Q9H334 UniProtKB Natural variant 514 514 . . . ID=VAR_075248;Note=In MRLIAF%3B nuclear and cytoplasmic aggregation%3B loss of transcriptional repression activity%3B loss of ability to self-associate%3B loss of interaction with FOXP2. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26647308;Dbxref=dbSNP:rs869025203,PMID:26647308 Q9H334 UniProtKB Natural variant 534 534 . . . ID=VAR_075249;Note=In MRLIAF%3B nuclear and cytoplasmic aggregation%3B loss of transcriptional repression activity%3B loss of ability to self-associate%3B loss of interaction with FOXP2. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26647308;Dbxref=dbSNP:rs587777855,PMID:26647308 Q9H334 UniProtKB Natural variant 570 570 . . . ID=VAR_065073;Note=Does not affect nuclear localization%3B no loss of transcriptional repression activity%3B no loss of ability to self-associate%3B no loss of interaction with FOXP2. N->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20848658,ECO:0000269|PubMed:20950788,ECO:0000269|PubMed:26647308;Dbxref=dbSNP:rs140161845,PMID:20848658,PMID:20950788,PMID:26647308 Q9H334 UniProtKB Natural variant 597 597 . . . ID=VAR_065074;Note=In MRLIAF%3B uncertain significance%3B does not affect nuclear localization%3B no loss of transcriptional repression activity%3B no loss of ability to self-associate%3B no loss of interaction with FOXP2. N->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20848658,ECO:0000269|PubMed:26647308;Dbxref=PMID:20848658,PMID:26647308 Q9H334 UniProtKB Natural variant 613 613 . . . ID=VAR_065075;Note=T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20950788;Dbxref=dbSNP:rs1318614471,PMID:20950788 Q9H334 UniProtKB Sequence conflict 138 138 . . . Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q9H334 UniProtKB Sequence conflict 173 173 . . . Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q9H334 UniProtKB Sequence conflict 205 205 . . . Note=L->V;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q9H334 UniProtKB Sequence conflict 210 212 . . . Note=GQP->ARA;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q9H334 UniProtKB Helix 470 479 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Beta strand 481 486 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Helix 488 498 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Helix 500 502 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Helix 506 519 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Beta strand 523 526 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Beta strand 533 536 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU Q9H334 UniProtKB Helix 538 543 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:2KIU